Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated:  6/12/2012
Rainier Clinical Research Center Inc.
mi
from
Renton, WA
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated: 6/12/2012
Rainier Clinical Research Center Inc.
mi
from
Renton, WA
Click here to add this to my saved trials
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated:  6/12/2012
University of Wisconsin-Madison
mi
from
Madison, WI
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps
Status: Enrolling
Updated: 6/12/2012
University of Wisconsin-Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Program Reinforcement Impacts Self Management (PRISM)
Program Reinforcement Impacts Self Management
Status: Enrolling
Updated:  6/13/2012
Pennsylvania State University
mi
from
Hershey, PA
Program Reinforcement Impacts Self Management (PRISM)
Program Reinforcement Impacts Self Management
Status: Enrolling
Updated: 6/13/2012
Pennsylvania State University
mi
from
Hershey, PA
Click here to add this to my saved trials
Program Reinforcement Impacts Self Management (PRISM)
Program Reinforcement Impacts Self Management
Status: Enrolling
Updated:  6/13/2012
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Program Reinforcement Impacts Self Management (PRISM)
Program Reinforcement Impacts Self Management
Status: Enrolling
Updated: 6/13/2012
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding
LIRAGLUTIDE AND ORLISTAT TREATMENT FOR PERSISTENT TYPE 2 DIABETES AFTER GASTRIC BANDING: A PILOT STUDY
Status: Enrolling
Updated:  6/13/2012
Brody School of Medicine at East Carolina University
mi
from
Greenville, NC
Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding
LIRAGLUTIDE AND ORLISTAT TREATMENT FOR PERSISTENT TYPE 2 DIABETES AFTER GASTRIC BANDING: A PILOT STUDY
Status: Enrolling
Updated: 6/13/2012
Brody School of Medicine at East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia
Comparison of Effectiveness of Glulisine and Lispro in Decreasing Post-Prandial Hyperglycemia in a Real-World Setting
Status: Enrolling
Updated:  6/13/2012
Camp Winona
mi
from
DeLeon Springs, FL
Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia
Comparison of Effectiveness of Glulisine and Lispro in Decreasing Post-Prandial Hyperglycemia in a Real-World Setting
Status: Enrolling
Updated: 6/13/2012
Camp Winona
mi
from
DeLeon Springs, FL
Click here to add this to my saved trials
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  6/18/2012
Profil Institute for Clinical Research
mi
from
Chula Vista, CA
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 6/18/2012
Profil Institute for Clinical Research
mi
from
Chula Vista, CA
Click here to add this to my saved trials
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  6/18/2012
VA San Diego Healthcare System
mi
from
San Diego, CA
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 6/18/2012
VA San Diego Healthcare System
mi
from
San Diego, CA
Click here to add this to my saved trials
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  6/18/2012
La Biomed Research Inst. At Harbor Ucla Med Ctr.
mi
from
Torrance, CA
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 6/18/2012
La Biomed Research Inst. At Harbor Ucla Med Ctr.
mi
from
Torrance, CA
Click here to add this to my saved trials
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  6/18/2012
Compass Research Phase 1, LLC
mi
from
Orlando, FL
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 6/18/2012
Compass Research Phase 1, LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  6/18/2012
Progressive Medical Research
mi
from
Port Orange, FL
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 6/18/2012
Progressive Medical Research
mi
from
Port Orange, FL
Click here to add this to my saved trials
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  6/18/2012
Vince and Associates Clinical Research
mi
from
Overland Park, KA
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 6/18/2012
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Click here to add this to my saved trials
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  6/18/2012
Central Kentucky Research Associates, Inc.
mi
from
Lexington, KY
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 6/18/2012
Central Kentucky Research Associates, Inc.
mi
from
Lexington, KY
Click here to add this to my saved trials
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  6/18/2012
Louisiana Research Associates, Inc.
mi
from
New Orleans, LA
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 6/18/2012
Louisiana Research Associates, Inc.
mi
from
New Orleans, LA
Click here to add this to my saved trials
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  6/18/2012
Jasper Clinic, Inc.
mi
from
Kalamazoo, MI
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 6/18/2012
Jasper Clinic, Inc.
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  6/18/2012
Kansas City University Of Medicine And Biosciences
mi
from
Kansas City, MO
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 6/18/2012
Kansas City University Of Medicine And Biosciences
mi
from
Kansas City, MO
Click here to add this to my saved trials
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  6/18/2012
Local Institution
mi
from
Portland, OR
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 6/18/2012
Local Institution
mi
from
Portland, OR
Click here to add this to my saved trials
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  6/18/2012
Regional Medical Clinic-Endocrinology
mi
from
Rapid City, SD
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 6/18/2012
Regional Medical Clinic-Endocrinology
mi
from
Rapid City, SD
Click here to add this to my saved trials
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  6/18/2012
Dallas Diabetes and Endocrine Center
mi
from
Dallas, TX
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 6/18/2012
Dallas Diabetes and Endocrine Center
mi
from
Dallas, TX
Click here to add this to my saved trials
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  6/18/2012
Local Institution
mi
from
Fairfax, VA
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 6/18/2012
Local Institution
mi
from
Fairfax, VA
Click here to add this to my saved trials
Evaluation of Exenatide in Patients With Diabetic Neuropathy
A Single-center, Proof of Concept, Randomized, Controlled Parallel Group Clinical Trial of the Effects of Exenatide Versus a Long Acting Insulin Analog for 18 Months to Evaluate the Efficacy of Exenatide Therapy in Patients With Diabetic Peripheral Neuropathy and Type 2 Diabetes
Status: Enrolling
Updated:  6/20/2012
University of Michigan Health System
mi
from
Ann Arbor, MI
Evaluation of Exenatide in Patients With Diabetic Neuropathy
A Single-center, Proof of Concept, Randomized, Controlled Parallel Group Clinical Trial of the Effects of Exenatide Versus a Long Acting Insulin Analog for 18 Months to Evaluate the Efficacy of Exenatide Therapy in Patients With Diabetic Peripheral Neuropathy and Type 2 Diabetes
Status: Enrolling
Updated: 6/20/2012
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Resveratrol-Leucine Metabolite Synergy in Pre-diabetes
Resveratrol-Leucine Metabolite Synergy in Pre-diabetes
Status: Enrolling
Updated:  6/21/2012
Facility: Vanderbilt University
mi
from
Nashville, TN
Resveratrol-Leucine Metabolite Synergy in Pre-diabetes
Resveratrol-Leucine Metabolite Synergy in Pre-diabetes
Status: Enrolling
Updated: 6/21/2012
Facility: Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients
Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients
Status: Enrolling
Updated:  6/22/2012
University of Wisconsin
mi
from
Madison, WI
Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients
Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients
Status: Enrolling
Updated: 6/22/2012
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus
Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus
Status: Enrolling
Updated:  6/22/2012
Atlanta Diabetes Association
mi
from
Atlanta, GA
Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus
Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus
Status: Enrolling
Updated: 6/22/2012
Atlanta Diabetes Association
mi
from
Atlanta, GA
Click here to add this to my saved trials
Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System
Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System - GLYCOAIM Study
Status: Enrolling
Updated:  6/22/2012
Catalina Research Institute
mi
from
Chino, CA
Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System
Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System - GLYCOAIM Study
Status: Enrolling
Updated: 6/22/2012
Catalina Research Institute
mi
from
Chino, CA
Click here to add this to my saved trials
Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System
Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System - GLYCOAIM Study
Status: Enrolling
Updated:  6/22/2012
Diabetes and Endocrine Associate
mi
from
La Mesa, CA
Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System
Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System - GLYCOAIM Study
Status: Enrolling
Updated: 6/22/2012
Diabetes and Endocrine Associate
mi
from
La Mesa, CA
Click here to add this to my saved trials
Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System
Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System - GLYCOAIM Study
Status: Enrolling
Updated:  6/22/2012
Infosphere
mi
from
West Hills, CA
Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System
Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System - GLYCOAIM Study
Status: Enrolling
Updated: 6/22/2012
Infosphere
mi
from
West Hills, CA
Click here to add this to my saved trials
Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System
Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System - GLYCOAIM Study
Status: Enrolling
Updated:  6/22/2012
Desert Endocrinology Clinical Research Center
mi
from
Henderson, NV
Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System
Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 System - GLYCOAIM Study
Status: Enrolling
Updated: 6/22/2012
Desert Endocrinology Clinical Research Center
mi
from
Henderson, NV
Click here to add this to my saved trials
Evaluate Tolerability of Myfortic®/Simulect® and Tacrolimus Without Steroids in Three Patient Populations
Study to Evaluate Tolerability of Myfortic With Simulect Induction and Tacrolimus Without Steroids in Three Patient Populations; 1: Kidney/Pancreas Transplants,2: Diabetic Kidney Transplants, and 3: Non-diabetic Kidney Transplants
Status: Enrolling
Updated:  6/25/2012
University of Texas Medical Branch
mi
from
Galveston, TX
Evaluate Tolerability of Myfortic®/Simulect® and Tacrolimus Without Steroids in Three Patient Populations
Study to Evaluate Tolerability of Myfortic With Simulect Induction and Tacrolimus Without Steroids in Three Patient Populations; 1: Kidney/Pancreas Transplants,2: Diabetic Kidney Transplants, and 3: Non-diabetic Kidney Transplants
Status: Enrolling
Updated: 6/25/2012
University of Texas Medical Branch
mi
from
Galveston, TX
Click here to add this to my saved trials
Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function
Phase 1 Open-Label Pharmacokinetic, Safety and Tolerability Study of a Single Subcutaneous Dose of Glymera (PB1023) Injection in Subjects With Normal Renal Function and Subjects With Impaired Renal Function
Status: Enrolling
Updated:  6/26/2012
Prism Research
mi
from
St Paul, MN
Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function
Phase 1 Open-Label Pharmacokinetic, Safety and Tolerability Study of a Single Subcutaneous Dose of Glymera (PB1023) Injection in Subjects With Normal Renal Function and Subjects With Impaired Renal Function
Status: Enrolling
Updated: 6/26/2012
Prism Research
mi
from
St Paul, MN
Click here to add this to my saved trials
Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function
Phase 1 Open-Label Pharmacokinetic, Safety and Tolerability Study of a Single Subcutaneous Dose of Glymera (PB1023) Injection in Subjects With Normal Renal Function and Subjects With Impaired Renal Function
Status: Enrolling
Updated:  6/26/2012
New Orleans Center for Clinical Research
mi
from
Knoxville, TN
Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function
Phase 1 Open-Label Pharmacokinetic, Safety and Tolerability Study of a Single Subcutaneous Dose of Glymera (PB1023) Injection in Subjects With Normal Renal Function and Subjects With Impaired Renal Function
Status: Enrolling
Updated: 6/26/2012
New Orleans Center for Clinical Research
mi
from
Knoxville, TN
Click here to add this to my saved trials
Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Monitoring as an Exercise Marker
Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Monitoring as an Exercise Marker
Status: Enrolling
Updated:  6/27/2012
University of Virginia
mi
from
Charlottesville, VA
Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Monitoring as an Exercise Marker
Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Monitoring as an Exercise Marker
Status: Enrolling
Updated: 6/27/2012
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Bone Health in Type 1 Diabetes
Pilot Study - Type 1 Diabetes and Bone Health
Status: Enrolling
Updated:  6/29/2012
Creighton University
mi
from
Omaha, NE
Bone Health in Type 1 Diabetes
Pilot Study - Type 1 Diabetes and Bone Health
Status: Enrolling
Updated: 6/29/2012
Creighton University
mi
from
Omaha, NE
Click here to add this to my saved trials
Type 2 Diabetes Self-management Intervention for Low-income Women
A Comprehensive Approach to Type 2 Diabetes Self-management for Low-income Women
Status: Enrolling
Updated:  7/10/2012
Meharry Medical College
mi
from
Nashville, TN
Type 2 Diabetes Self-management Intervention for Low-income Women
A Comprehensive Approach to Type 2 Diabetes Self-management for Low-income Women
Status: Enrolling
Updated: 7/10/2012
Meharry Medical College
mi
from
Nashville, TN
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Clinical Research Advantage/Desert Clinical Research, LLC
mi
from
Mesa, AZ
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Clinical Research Advantage/Desert Clinical Research, LLC
mi
from
Mesa, AZ
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Desert Sun Clinical Research, LLC
mi
from
Tucson, AZ
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Desert Sun Clinical Research, LLC
mi
from
Tucson, AZ
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Paul W. Davis, MD, PA
mi
from
Pine Bluff, AR
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Paul W. Davis, MD, PA
mi
from
Pine Bluff, AR
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Southland Clinical Research Center, Inc.
mi
from
Fountain Valley, CA
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Southland Clinical Research Center, Inc.
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Valley Research
mi
from
Fresno, CA
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Valley Research
mi
from
Fresno, CA
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Del Rosario Medical Clinic, Inc.
mi
from
Huntington Park, CA
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Del Rosario Medical Clinic, Inc.
mi
from
Huntington Park, CA
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Scripps Whittier Diabetes Institute
mi
from
Chula Vista, CA
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Scripps Whittier Diabetes Institute
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
National Research Institute
mi
from
Los Angeles, CA
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
National Research Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Spectrum Clinical Research Institute, Inc
mi
from
Moreno Valley, CA
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Spectrum Clinical Research Institute, Inc
mi
from
Moreno Valley, CA
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Sacramento Heart and Vascular Medical Associates
mi
from
Sacramento, CA
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Sacramento Heart and Vascular Medical Associates
mi
from
Sacramento, CA
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Infosphere Clinical Research, Inc.
mi
from
West Hills, CA
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Infosphere Clinical Research, Inc.
mi
from
West Hills, CA
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
PAB Clinical Research
mi
from
Brandon, FL
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
PAB Clinical Research
mi
from
Brandon, FL
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Florida Research Network
mi
from
Gainesville, FL
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Florida Research Network
mi
from
Gainesville, FL
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Newphase Clinical Trials, Inc.
mi
from
Miami Beach, FL
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Newphase Clinical Trials, Inc.
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Suncoast Clinical Research
mi
from
Palm Harbor, FL
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Suncoast Clinical Research
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/15/2012
Regenerate Clinical Trials
mi
from
South Miami, FL
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/15/2012
Regenerate Clinical Trials
mi
from
South Miami, FL
Click here to add this to my saved trials